P-glycoprotein expression in de novo acute myeloid leukemia.

doi:10.3109/10428199709059682

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

P-glycoprotein expression in de novo acute myeloid leukemia.

Leukemia & lymphoma - 1 Oct 1997

Del Poeta G, Venditti A, Aronica G, Stasi R, Cox M C, Buccisano F, Bruno A, Tamburini A, Suppo G, Simone M D, Epiceno A M, Del Moro B, Masi M, Papa G, Amadori S

Abstract excerpt

Detection of the multidrug resistance P-glycoprotein (PGP) phenotype was performed at the time of diagnosis in 223 patients with acute myeloid leukemia (AML) by flow cytometry using C219 Monoclonal Antibody (MoAb). On the other hand, JSB1 MoAb was tested in 173 of these samples. At onset, PGP was...

Topics

ATP Binding Cassette Transporter, Subfamily B, Member 1
Acute Disease
Adolescent
Adult
Aged
Aged, 80 and over
Flow Cytometry
Gene Expression Regulation, Neoplastic
Humans
Leukemia, Myeloid
Middle Aged
Phenotype
Prognosis

Source

Open in PubMed

Identifiers

PMID: 9402325
DOI: 10.3109/10428199709059682

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9402325-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics